This study tests an experimental vaginal insert (ABI-2280) to see if it can safely clear persistent high-risk human papillomavirus (HPV) infection in women aged 25 to 55. Participants must have had HPV for at least a year with no serious cervical changes. The study compares diffe…
Phase: PHASE1, PHASE2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC